4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001916048-26-000009
Chief Commercial Officer sold 7,438 shares at $26.87 ($199,885)
- Chief Commercial Officer acquired 7,438 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Warren Eric Chief Commercial Officer | 2026-07-21 | Option exercise 10b5-1 | +7,438 | $13.24 | $98,479 | 45,838 | D |
| Warren Eric Chief Commercial Officer | 2026-07-21 | Sale 10b5-1 | −7,438 | $26.87 | $199,885 | 38,400 | D |
| Derivatives | |||||||
| Warren Eric Chief Commercial Officer | 2026-07-21 | Option exercise · Stock Option 10b5-1 | −7,438 | 245,438 | D | ||
| Open-market sales · 7,438 sh · avg $26.87 · $199,885 | |||||||
Loading xslF345X06/wk-form4_1784846362.xml…